BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:CANCELLED: Tailored proteins and polypeptides as versatile buildin
 g blocks for nanomedicine applications
DTSTART:20130225T131500
DTSTAMP:20260511T054259Z
UID:61a603e4c25554c8d8fa55e3725efa48a41016ed991c687a48c412fb
CATEGORIES:Conferences - Seminars
DESCRIPTION:Tanja Weil of Universitat Ulm\nBio : Tanja Weil joined Ulm Uni
 versity as Director of the Institute of Organic Chemistry III and Macromol
 ecular Chemistry in 2010. She studied chemistry (1993–1998) at the TU Br
 aunschweig (Germany) and the University of Bordeaux I (France) and complet
 ed her PhD at the MPI for Polymer Research under the supervision of K. Mü
 llen. In 2003 she received the Otto Hahn Medal of the Max Planck Society. 
 From 2002 to 2008 she managed different leading positions at Merz Pharmace
 uticals GmbH (Frankfurt) from Section Head Medicinal Chemistry to Director
  of Chemical Research and Development. In 2005 Tanja Weil was also appoint
 ed to the MPI for Polymer Research and in 2008 she accepted an Associate P
 rofessor position at the National University of Singapore. In 2011 she bec
 ame member of the Board of Directors of the International Graduate School 
 for Molecular Medicine and in 2011 she has co-founded the “Ulm Competenc
 e Center for Peptide Pharmaceuticals” (UPEP). In 2012 Tanja Weil has bee
 n awarded the ERC Synergy Grant together with Fedor Jelezko and Martin Ple
 nio. Her current scientific interests include the biohybrid materials\, de
 ndrimers and artificial proteins.\nProteins possess attractive features su
 ch as a large number of reactive surface functionalities\, an accurately k
 nown chain length and a defined number of functional groups at distinct lo
 cations within the peptide backbone\, low size-dispersity as well as intri
 nsic biocompatibility. Therefore\, they represent attractive and versatile
  precursors for the preparation of giant biopolymers\, macromolecular drug
 s as well as supramolecular\, bioactive assemblies. They offer great oppor
 tunities for the stabilization of nanoparticles for bioimaging application
 s and allow the attachment of large numbers of drugs and contrast reagents
  or the construction of defined supramolecular assemblies with tunable bio
 logical activities. Such protein-derived biohybrids have a great potential
  for in vivo therapy and pave the way to intelligent vehicles for nanomedi
 cine applications.
LOCATION:MXF 1 https://plan.epfl.ch/?room==MXF%201
STATUS:CANCELLED
END:VEVENT
END:VCALENDAR